| Sputum microRNA profiling: a novel approach for the early detection of non-small cell lung cancer WH Roa, JO Kim, R Razzak, H Du, L Guo, R Singh, S Gazala, S Ghosh, ... Clinical and Investigative Medicine 35 (5), E271-E281, 2012 | 95 | 2012 |
| Non-small cell lung cancer detection using microRNA expression profiling of bronchoalveolar lavage fluid and sputum JO Kim, S Gazala, R Razzak, L Guo, S Ghosh, WH Roa, ELR Bedard Anticancer Research 35 (4), 1873-1880, 2015 | 54 | 2015 |
| MicroRNA expression profiling of sputum for the detection of early and locally advanced non-small-cell lung cancer: a prospective case–control study R Razzak, ELR Bédard, JO Kim, S Gazala, L Guo, S Ghosh, A Joy, T Nijjar, ... Current Oncology 23 (2), 86-94, 2016 | 35 | 2016 |
| Treatment and prevention of brain metastases in small cell lung cancer R Rittberg, S Banerji, JO Kim, S Rathod, DE Dawe American journal of clinical oncology 44 (12), 629-638, 2021 | 32 | 2021 |
| Long-term outcomes of fractionated stereotactic radiation therapy for pituitary adenomas at the BC Cancer Agency JO Kim, R Ma, R Akagami, M McKenzie, M Johnson, E Gete, A Nichol International Journal of Radiation Oncology* Biology* Physics 87 (3), 528-533, 2013 | 32 | 2013 |
| Metabolic Signatures of Lung Cancer in Sputum and Exhaled Breath Condensate Detected by 1H Magnetic Resonance Spectroscopy: A Feasibility Study N Ahmed, T Bezabeh, OB Ijare, R Myers, R Alomran, M Aliani, Z Nugent, ... Magnetic resonance insights 9, MRI. S40864, 2016 | 30 | 2016 |
| Waiting time intervals for non-small cell lung cancer diagnosis and treatment in Alberta: quantification of intervals and identification of risk factors associated with delays JOA Kim, F Davis, C Butts, M Winget Clinical Oncology 28 (12), 750-759, 2016 | 25 | 2016 |
| SABR-BRIDGE: Stereotactic ABlative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts During the COVID-19 … B Kidane, J Spicer, JO Kim, PO Fiset, B Abdulkarim, R Malthaner, ... Frontiers in Oncology 10, 580189, 2020 | 20 | 2020 |
| Evaluating the impact of the COVID-19 pandemic on new cancer diagnoses and oncology care in Manitoba KM Decker, P Lambert, A Feely, O Bucher, JO Kim, P Hebbard, ... Current Oncology 28 (4), 3081-3090, 2021 | 19 | 2021 |
| Impact of spironolactone exposure on prostate cancer incidence amongst men with heart failure: A Pharmacoepidemiological study BM Hiebert, BW Janzen, RM Sanjanwala, AD Ong, RD Feldman, JO Kim British journal of clinical pharmacology 87 (4), 1801-1813, 2021 | 17 | 2021 |
| Impact of personalized genetic breast cancer risk estimation with polygenic risk scores on preventive endocrine therapy intention and uptake JO Kim, DJ Schaid, CM Vachon, A Cooke, FJ Couch, CA Kim, JP Sinnwell, ... Cancer Prevention Research 14 (2), 175-184, 2021 | 12 | 2021 |
| Population-based study of cardiovascular mortality among patients with prostate cancer treated with radical external beam radiation therapy with and without adjuvant androgen … J Kim, M Vaid, S Tyldesley, R Woods, T Pickles International Journal of Radiation Oncology* Biology* Physics 80 (3), 742-750, 2011 | 12 | 2011 |
| Dose-escalated hypofractionated intensity-modulated radiation therapy with concurrent chemotherapy for inoperable or unresectable non-small cell lung cancer JO Kim, KP Chu, A Fairchild, S Ghosh, C Butts, Q Chu, Z Gabos, AA Joy, ... American Journal of Clinical Oncology 40 (3), 294-299, 2017 | 11 | 2017 |
| Abscopal resolution of a hepatic metastasis in a patient with metastatic cholangiocarcinoma following radical stereotactic body radiotherapy to a synchronous early stage non … JO Kim, CA Kim Cureus 11 (2), 2019 | 9 | 2019 |
| Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a … JO Kim, MO McDonald, A Ong, R Koul, A Dubey, W Hunter, S Ahmed, ... Radiation Oncology 16, 1-6, 2021 | 8 | 2021 |
| Does dissemination of guidelines alone increase the use of palliative single-fraction radiotherapy? Initial report of a longitudinal change management campaign at a provincial … JO Kim, N Hanumanthappa, YT Chung, J Beck, R Koul, B Bashir, A Cooke, ... Current Oncology 27 (4), 190-197, 2020 | 8 | 2020 |
| Comparative metabolomics studies of blood collected in streck and heparin tubes from lung cancer patients E Goldberg, S Ievari-Shariati, B Kidane, J Kim, S Banerji, G Qing, ... PloS one 16 (4), e0249648, 2021 | 7 | 2021 |
| Impact of pre-treatment NLR and other hematologic biomarkers on the outcomes of early-stage non-small-cell lung cancer treated with stereotactic body radiation therapy M Aduquaye, S Dube, B Bashir, A Chowdhury, N Ahmed, A Leylek, J Kim, ... Current Oncology 29 (1), 193-208, 2022 | 6 | 2022 |
| Data-driven identification of plasma metabolite clusters and metabolites of interest for potential detection of early-stage non-small cell lung cancer cases versus cancer-free … JO Kim, R Balshaw, C Trevena, S Banerji, L Murphy, D Dawe, L Tan, ... Cancer & Metabolism 10 (1), 16, 2022 | 5 | 2022 |
| Population-based Assessment of Intermittent Androgen Deprivation Therapy Utilization for Relapsed, Nonmetastatic, Hormone-sensitive Adenocarcinoma of the Prostate BW Janzen, A Ong, M Penner, R Koul, A Dubey, S Ahmed, B Bashir, ... American Journal of Clinical Oncology 43 (12), 865-871, 2020 | 4 | 2020 |
Sunita GhoshUniversity of Alberta在 ualberta.ca 的电子邮件经过验证
